Literature DB >> 18438465

A fast algorithm for solving a linear feasibility problem with application to Intensity-Modulated Radiation Therapy.

Gabor T Herman1, Wei Chen.   

Abstract

The goal of Intensity-Modulated Radiation Therapy (IMRT) is to deliver sufficient doses to tumors to kill them, but without causing irreparable damage to critical organs. This requirement can be formulated as a linear feasibility problem. The sequential (i.e., iteratively treating the constraints one after another in a cyclic fashion) algorithm ART3 is known to find a solution to such problems in a finite number of steps, provided that the feasible region is full dimensional. We present a faster algorithm called ART3+. The idea of ART3+ is to avoid unnecessary checks on constraints that are likely to be satisfied. The superior performance of the new algorithm is demonstrated by mathematical experiments inspired by the IMRT application.

Entities:  

Year:  2008        PMID: 18438465      PMCID: PMC2346447          DOI: 10.1016/j.laa.2006.11.009

Source DB:  PubMed          Journal:  Linear Algebra Appl        ISSN: 0024-3795            Impact factor:   1.401


  4 in total

1.  A fast optimization algorithm for multicriteria intensity modulated proton therapy planning.

Authors:  Wei Chen; David Craft; Thomas M Madden; Kewu Zhang; Hanne M Kooy; Gabor T Herman
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  Perturbation-resilient block-iterative projection methods with application to image reconstruction from projections.

Authors:  R Davidi; G T Herman; Y Censor
Journal:  Int Trans Oper Res       Date:  2008-02-11       Impact factor: 4.193

3.  Robotic Delivery of Complex Radiation Volumes for Small Animal Research.

Authors:  Mohammad Matinfar; Iulian Iordachita; John Wong; Peter Kazanzides
Journal:  IEEE Int Conf Robot Autom       Date:  2010-07-15

4.  Efficient Controls for Finitely Convergent Sequential Algorithms.

Authors:  Wei Chen; Gabor T Herman
Journal:  ACM Trans Math Softw       Date:  2010-04       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.